Advertisement

Topics

Actelion purchased by J&J, spins out Idorsia

05:40 EDT 19 Jun 2017 | SmartBrief

Johnson & Johnson's Janssen Pharmaceutical completed its Actelion acquisition for $30 billion in cash.  -More

Original Article: Actelion purchased by J&J, spins out Idorsia

NEXT ARTICLE

More From BioPortfolio on "Actelion purchased by J&J, spins out Idorsia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...